Keywords: clinical, trial, news, brief, canadian, firm, aeterna

Clinical Trial News In Brief

Article | 17 February 1998

Print This

Canadian firm Aeterna has started enrolling patients in a Phase I/IItrial of Psovascar, an angiogenesis inhibitor based on its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in